An Bang Lu
Vermogen: 16 M $ op 31-05-2026
Vermogen: 16 M $ op 31-05-2026
An Bang Lu is currently Chief Executive Officer & Executive Director at VISEN Pharmaceuticals (Shanghai) Co., Ltd. and Chief Executive Officer & Executive Director at VISEN Pharmaceuticals since 2021.
Formerly, Mr. Lu was President, General Manager & Head-Greater China at Takeda Pharmaceutical Co., Ltd. from 2010 to 2014.
Education includes an undergraduate degree from Taipei Medical University, conferred in 1989.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-01-2026 | 5.326.250 ( 4,68% ) | 16 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| VISEN PHARMACEUTICALS | Algemeen Directeur | 07-11-2018 |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops endocrine disease therapies | Algemeen Directeur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | President | 01-01-2014 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Taipei Medical University
Taipei Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops endocrine disease therapies | Health Technology |
VISEN Pharmaceuticals
VISEN Pharmaceuticals Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes paradigm-shifting endocrine therapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau